An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Seoul National University Hospital, Seoul, Korea, Republic of
Inje University, Haeundae paik hospital, Busan, Korea, Republic of
SecondXianJiaotongU, Xi'an, Shanxi, China
Haeundae paik hospital, inje university, Busan, Korea, Republic of
the First Hospital of China Medical University, Shenyang, Liaoning, China
University of Louisville, Louisville, Kentucky, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.